NCT01741012View on ClinicalTrials.gov

Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

November 30, 2015

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Gardasil

0.5 ml Gardasil vaccine in single dose prefilled syringes at Visit 2, Visit 4 and Visit 6

Trial Locations (1)

48201

DCaTS-Clinical Research Center, Detroit

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Wayne State University

OTHER

NCT01741012 - Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients | Biotech Hunter | Biotech Hunter